Search company, investor...

Founded Year

2013

Stage

Acquired | Acquired

Total Raised

$142M

Valuation

$0000 

About True North Therapeutics

True North Therapeutics operates as a clinical-stage biopharmaceutical company. Its lead product candidate, TNT009, is designed to selectively inhibit a target in the classical complement pathway and its antibody drug development is focused on the treatment of certain rare diseases mediated by the complement system. It was founded in 2013 and is based in South San Francisco, California.

Headquarters Location

951 Gateway Boulevard

South San Francisco, California, 94080,

United States

650-872-4700

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo
You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo

True North Therapeutics Patents

True North Therapeutics has filed 11 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/20/2016

10/29/2019

Monoclonal antibodies, Complement system, Immune system, Immunology, Acetylcholinesterase inhibitors

Grant

Application Date

12/20/2016

Grant Date

10/29/2019

Title

Related Topics

Monoclonal antibodies, Complement system, Immune system, Immunology, Acetylcholinesterase inhibitors

Status

Grant

Latest True North Therapeutics News

Abzenas partner True North Therapeutics subject of US$825m takeover

Mar 16, 2020

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored ND2A Group with offices at 677 Craig Rd, Suite 216, Creve Coeur, Missouri 63141 USA. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters here: Contact ND2A Group . All rights reserved. All other trademarks recognized. Copyright © 2020 ND2A Group. Site developed by Alacrify Ltd .

True North Therapeutics Frequently Asked Questions (FAQ)

  • When was True North Therapeutics founded?

    True North Therapeutics was founded in 2013.

  • Where is True North Therapeutics's headquarters?

    True North Therapeutics's headquarters is located at 951 Gateway Boulevard, South San Francisco.

  • What is True North Therapeutics's latest funding round?

    True North Therapeutics's latest funding round is Acquired.

  • How much did True North Therapeutics raise?

    True North Therapeutics raised a total of $142M.

  • Who are the investors of True North Therapeutics?

    Investors of True North Therapeutics include Bioverativ, Perceptive Advisors, HBM Healthcare Investments, Franklin Templeton, Redmile Group and 12 more.

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.